EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary figures for the 2024/25 fiscal year; revenue outlook for the new 2025/26 fiscal year below market expectations

Preliminary figures for fiscal year 2024/25
Based on preliminary, unaudited figures, thyssenkrupp nucera expects group sales of €845 million for fiscal year 2024/25 (2023/24: €862 million), which is slightly below the previous sales guidance of €850 million to €920 million. Group EBIT is positive and is expected to amount to around €2 million. This represents an increase in EBIT against the previous year (2023/24: €-14 million) and is in the upper half of the forecast range of €-7 million to €7 million. thyssenkrupp nucera also generated a positive free cash flow and continues to finance itself from its operating activities.
On segment level, Green Hydrogen (gH2) and Chlor-Alkali (CA) are expected to meet the guidance for sales and EBIT. The gH2 segment achieved sales of €459 million (2023/24: €524 million) and increased EBIT to €-56 million (2023/24: €-76 million). In the CA segment, sales rose to €386 million (2023/24: €338 million), while EBIT was €58 million (2023/24: €62 million).
Order intake in the past financial year 2024/25 amounted to €348 million (2023/24: €636 million). Of this, €26 million was attributable to the gH2 segment (2023/24: €356 million) and €322 million to the CA segment (2023/24: €279 million). The order backlog as of 30 September 2025 was around €0.6 billion.

Expectations for fiscal year 2025/26
In the opinion of the Management Board, the sales outlook for the new financial year 2025/26 is below current market expectations. The ongoing reluctance to make final investment decisions against the backdrop of a continuing challenging market environment for green hydrogen is having a negative impact on the expected sales for the 2025/26 fiscal year. Current market expectations do not sufficiently reflect these effects from the company's perspective (Bloomberg consensus estimate of 24 November 2025, group sales for 2025/26: €729 million).
For the 2025/26 financial year, the Management Board expects group sales of between €500 million and €600 million (2024/25: €845 million). The sales development is based primarily on the existing order backlog. Additional orders in the green hydrogen sector are not expected to have a significant impact on sales until following years.
thyssenkrupp nucera has already initiated measures to mitigate the lower cost absorption due to lower sales and thus ultimately the impact on earnings. In this context, the Management Board expects group EBIT to be between €-30 million and €0 million (2024/25: €2 million).

All published figures and statements are preliminary and unaudited. The detailed Q4/FY 2024/25 results and the sales and EBIT guidance for the Group and the segments for fiscal year 2025/26 will be published in the 2024/25 Annual Report on 17 December 2025 at 7:00 a.m. CET.
Key financial figures: Explanations of the financial performance indicators used can be found in thyssenkrupp nucera's 2023/24 Annual Report on pages 53 to 54, available at the following link: https://investors.thyssenkrupp-nucera.com/investors/publications